| scholarly article | Q13442814 |
| P2093 | author name string | Pee-Win Chong | |
| Barbara Grube | |||
| Linda Riede | |||
| Wen-Fen Chong | |||
| P2860 | cites work | Management of Obesity in Adults: European Clinical Practice Guidelines | Q22241943 |
| Long term pharmacotherapy for obesity and overweight: updated meta-analysis. | Q22242086 | ||
| Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates | Q24652265 | ||
| Obesity prevalence from a European perspective: a systematic review | Q33340814 | ||
| A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women | Q34002443 | ||
| Possible anti-obesity therapeutics from nature – A review | Q34132782 | ||
| A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control | Q34767647 | ||
| The psychiatric side-effects of rimonabant | Q34990771 | ||
| Porcine pancreatic alpha-amylase inhibition by the kidney bean (Phaseolus vulgaris) inhibitor (alpha-AI1) and structural changes in the alpha-amylase inhibitor complex | Q35661258 | ||
| The burden of overweight and obesity in the Asia-Pacific region | Q36795858 | ||
| The epidemiology of obesity: the size of the problem | Q37099078 | ||
| Anti-obesity drugs: past, present and future | Q38036925 | ||
| Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial | Q42950914 | ||
| Withdrawal of sibutramine in Europe | Q43166872 | ||
| An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects | Q43238459 | ||
| Waist circumference as a measurement of obesity in the Netherlands Antilles; associations with hypertension and diabetes mellitus | Q43795686 | ||
| Food preferences in human obesity: carbohydrates versus fats | Q44038049 | ||
| Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals | Q44815365 | ||
| Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations | Q47151410 | ||
| Weight cycling and mortality in a large prospective US study | Q47329262 | ||
| Prevalence of weight cycling and its relation to health indicators in Finland | Q47386694 | ||
| Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. | Q54255594 | ||
| Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. | Q54656315 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 645-651 | |
| P577 | publication date | 2013-09-05 | |
| P1433 | published in | Obesity | Q15763232 |
| P1476 | title | Weight reduction and maintenance with IQP-PV-101: a 12-week randomized controlled study with a 24-week open label period | |
| P478 | volume | 22 |
| Q40234695 | Beneficial effect of a high number of copies of salivary amylase AMY1 gene on obesity risk in Mexican children. |
| Q64248664 | Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects |
| Q28279770 | Drug interventions for the treatment of obesity in children and adolescents |
| Q51269837 | Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study. |
| Q97073024 | GlycoLite™ and helps to reduce body weight: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q92486039 | Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements |
| Q90381119 | Regular intake of white kidney beans extract (Phaseolus vulgaris L.) induces weight loss compared to placebo in obese human subjects |
| Q55023121 | Systematic Review and Meta-Analysis of a Proprietary Alpha-Amylase Inhibitor from White Bean (Phaseolus vulgaris L.) on Weight and Fat Loss in Humans. |
Search more.